肝硬化腹水的诊治  

Diagnosis and therapy of ascites in liver cirrhosis

作　　者：程然 徐小元[1] Cheng Ran;Xu Xiaoyuan(Department of Infectious Diseases,Peking University First Hospital,Beijing 100034,China)

机构地区：[1]北京大学第一医院感染疾病科,北京100034

出　　处：《临床荟萃》2018年第11期921-924,共4页Clinical Focus

基　　金：国家科技重大专项(2018ZX09206005-002;2017ZX10302201);北京市自然科学基金(D161100002716003;D161100002716002;D171100003117005)

摘　　要：腹水是肝硬化失代偿期主要并发症之一。腹水的形成往往提示预后不良,发生自发性细菌性腹膜炎(SBP)、肝肾综合征(HRS)等并发症的概率大大增高。规范化处理肝硬化腹水及其并发症可提高患者的生存质量和生存率。本文结合近期肝硬化相关指南对腹水诊治进行概述。Ascites is one of the major complications of liver cirrhosis and is associated with a poor prognosis. Patients with ascites are at high risk of developing complications such as spontaneous bacterial peritonitis and progressive renal impairment. Adequate management of cirrhotic ascites and its complications improves quality of life and increases survivaI. This article summarizes the advances in diagnosis and therapy of ascites in combination with guidelines.

关 键 词：肝硬化 腹水 腹膜炎 肝肾综合征 

分 类 号：R575.2[医药卫生—消化系统]